S3 Guideline for Bladder Cancer Claim and Reality a critical Commentary from the Guideline Coordinators

被引：0
|
作者：
Retz, M. [1 ]
Maisch, P. [1 ]
Gschwend, J. E. [1 ]
机构：
[1] Tech Univ Munich, Urol Klin & Poliklin, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
来源：
UROLOGE | 2016年 / 55卷 / 09期
关键词：
D O I：
10.1007/s00120-016-0196-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1188 / 1191
页数：4
相关论文
共 50 条
  • [1] S3-Leitlinie HarnblasenkarzinomAnspruch und Wirklichkeit – ein kritischer Kommentar der LeitlinienkoordinatorenS3 guideline for bladder cancerClaim and reality – a critical commentary from the guideline coordinators
    M. Retz
    P. Maisch
    J. E. Gschwend
    Der Urologe, 2016, 55 (9): : 1188 - 1191
  • [2] Short version of the German S3 guideline for bladder cancer
    Retz, M.
    Gschwend, J. E.
    Maisch, P.
    UROLOGE, 2016, 55 (09): : 1173 - 1187
  • [3] Risks and prevention of prostate cancer - Commentary on the new S3 guideline
    Schmitz-Draeger, B. J.
    Bismarck, E.
    Luemmen, G.
    UROLOGE, 2010, 49 (02): : 233 - 237
  • [4] S3 guideline on cervical cancer
    Fehm, Tanja
    Mallmann, Peter
    GYNAKOLOGE, 2019, 52 (08): : 568 - 569
  • [5] The S3 Guideline Exocrine Pancreatic Cancer
    Seufferlein, Thomas
    Adler, Guido
    MEDIZINISCHE KLINIK, 2009, 104 (11) : 869 - 874
  • [6] Esophageal Cancer S3 Guideline updated
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (12) : 737 - 738
  • [7] S3 Guideline Was Not Mentioned
    Thomasius, Friederike
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2012, 109 (05): : 76 - 77
  • [8] News from the updated S3 guideline
    Widhalm, K.
    Fallmann, K.
    PADIATRIE UND PADOLOGIE, 2023, 58 (02): : 92 - 93
  • [9] S3 Guideline for Skin Cancer Prevention updated
    Mugele, Katrin
    Bunde, Henriette
    Bauer, Andrea
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (05) : 299 - 300
  • [10] Updating the S3 Guideline on Pancreatic Cancer - now as a Living Guideline with annual Updates
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (06)
12345